Thursday, 9 April 2026
PERSPECTA
News from every angle
All
World
Politics
Business
Technology
Finance
Science
Health
Culture
Opinion
Environment
← Back to headlines
Bristol-Myers Squibb (BMY) Announces Positive Data from the Phase 3 SCOUT-HCM Trial of Camzyos
2 Apr, 14:46 — 2 Apr, 14:46
Post
Share
Copy link
Embed
Sources
Sort: Relevance
Sort: Latest
Sort: Bias (L→R)
Sort: Bias (R→L)
Sort: Factuality
left
center
right
Showing 1 of 1 sources
Yahoo
Mostly Factual
6d ago
Bristol-Myers Squibb (BMY) Announces Positive Data from the Phase 3 SCOUT-HCM Trial of Camzyos
Read full article →
Something wrong with this story? Report an issue
Related Stories
Philippines Grapples with Persistent Unsafe Abortions Despite Ban
just now
JW Pharmaceutical secures GLP-1 drug rights in $81m deal
7m ago
Man sentenced for opioid possession and distribution in Denmark
10m ago
Experts discuss workplace bullying in Finland
12m ago
Thursday, 9 April 2026
Explore
Log in
Sign up
en
PERSPECTA
News from every angle
